 Shares of Corbus Pharmaceuticals Holdings Inc NASDAQ:CRBP have been given a consensus rating of Buy by the nine analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seven have issued a buy recommendation on the company. The ... 